Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
KOREA E & EX
Ampronix

Novel Inflator Suitable for Multiple Interventional Balloon Systems

By HospiMedica International staff writers
Posted on 15 Jul 2013
Image: The basixTOUCH high-pressure balloon inflator (Photo courtesy of Merit Medical).
Image: The basixTOUCH high-pressure balloon inflator (Photo courtesy of Merit Medical).
A novel high-pressure syringe for use in catheterization laboratories could potentially replace multiple inflation systems by offering a wide range of available pressure.

The basixTOUCH high-pressure balloon inflator delivers pressure of up to 3546 kPa (or 35 atmospheres) for inflating an angioplasty balloon or other interventional device, continuously measuring the pressure within the balloon. Once the intervention has ended, the balloon can be quickly deflated, dropping the pressure rapidly thanks to a quick-release handle. The system can be prepped and primed single-handedly, and eliminates the need to use multiple inflation devices in some advanced interventional cases, thanks to its high-pressure range.

Two important features of the device include an ergonomic handle and threads that ensure high pressures can be reached rapidly, reaching maximum with less than three clockwise rotations of the handle. The system is supplied with a 30 mL syringe barrel that accommodates additional fluid for large balloons. The basixTOUCH high-pressure balloon inflator is a product of Merit Medical (South Jordan, UT, USA), and has been approved by the US Food and Drug Administration (FDA).

“We believe the introduction of the basixTOUCH clearly places Merit in the worldwide leadership position for inflation devices which are used in numerous interventional and peripheral procedures,” said Fred Lampropoulos, chairman and CEO of Merit Medical. “This device and its derivatives have the potential, when combined with other devices such as our hemostasis valves, to become the largest single revenue producing product in Merit’s history.”

Related Links:
Merit Medical



Inditherm
Harloff
JD Honigberg International

Channels

Critical Care

view channel

Little Evidence Supports Opioid Use for Chronic Pain

A new study reveals that there is paltry evidence for the long-term safety and efficacy of opioids in the treatment of chronic pain. Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled... Read more

Women's Health

view channel

Pregnant Women in Austria Experience Iodine Deficiency

A new study suggests that pregnant women in Austria have a potentially clinically significant iodine deficiency which could impair embryonic brain development. Researchers at the Medical University of Vienna (Austria) conducted a cross-sectional investigation of urinary iodine excretion in 246 pregnant women (2 in the... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.